drugset / Trial / NCT01878812
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Quadrivalent Influenza Vaccine, Fluarix/Influsplit Tetra® (2013/2014 Season), in Adults 18 Years of Age and Older
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The purpose of this study is to assess, in adults 18 years of age and above, the immunogenicity and reactogenicity of the seasonal influenza vaccine, Fluarix/Influsplit Tetra containing the four influenza strains (two A strains and two B strains) for the 2013/2014 season.
Timeline
- Start
- 2013-07-11
- Primary completion
- 2013-08-05
- Completion
- 2013-08-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluarix/Influsplit Tetra® | Vaccine | — | Intramuscular |